Clinical Trials Browser

Has results × Leukemia, Myeloid, Acute × Brentuximab Vedotin × Clear all

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT01461538 2016-03-04

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML)

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies